Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Cardiology

Journal Scan / Consensus and Guidelines · September 08, 2016

Dual Antiplatelet Therapy Involves Tradeoff Between Reduced Thrombosis and MI and Increased Bleeding

Journal of the American College of Cardiology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of the American College of Cardiology
Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
J Am Coll Cardiol 2016 Sep 06;68(10)1116-1139, JA Bittl, U Baber, SM Bradley, DN Wijeysundera

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading